2024-04-24 16:17 | CC:VIV | Avivagen Inc (2) | 0.005 | News Release200 | Avivagen makes assignment into bankruptcy |
2024-03-06 17:31 | CC:VIV | Avivagen Inc (2) | 0.005 | Cease Trade/Suspend Company180 | Avivagen suspended by OSC |
2024-03-06 08:00 | CC:VIV | Avivagen Inc (2) | 0.005 | Halt Trading170 | Avivagen halted at the open |
2023-10-17 13:16 | CC:VIV | Avivagen Inc (2) | 0.01 | News Release200 | Avivagen receives 500-kilogram OxC-beta order |
2023-09-29 11:24 | CC:VIV | Avivagen Inc (2) | 0.01 | News Release200 | Avivagen loses $932,918 in Q3 2023 |
2023-09-28 19:20 | CC:VIV | Avivagen Inc (2) | 0.01 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-09-28 19:19 | CC:VIV | Avivagen Inc (2) | 0.01 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-07-31 17:10 | CC:VIV | Avivagen Inc (2) | 0.015 | News Release200 | Avivagen receives patent allowance in Brazil, Canada |
2023-07-24 09:58 | CC:VIV | Avivagen Inc (2) | 0.015 | News Release200 | Avivagen receives orders for 1.1 tonnes of OxC-beta |
2023-06-06 16:13 | CC:VIV | Avivagen Inc (2) | 0.015 | News Release200 | Avivagen loses $1.24-million in Q2 |
2023-06-06 07:53 | CC:VIV | Avivagen Inc (2) | 0.015 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-06-06 07:53 | CC:VIV | Avivagen Inc (2) | 0.015 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-25 11:55 | CC:VIV | Avivagen Inc (2) | 0.015 | News Release200 | Avivagen receives 400 kg OxC-beta order from customer |
2023-05-18 08:24 | CC:VIV | Avivagen Inc (2) | 0.015 | News Release200 | Avivagen puts itself on the block, reduces staff |